Hepatobest Tablet contains Ursodeoxycholic Acid 300mg, a bile acid used primarily to treat various hepatobiliary disorders. It is indicated for the dissolution of cholesterol gallstones in patients who prefer nonsurgical treatment and have functioning gallbladders. Additionally, Hepatobest is effective in managing primary biliary cholangitis (PBC), a chronic liver disease characterized by progressive destruction of intrahepatic bile ducts. Ursodeoxycholic acid works by reducing the cholesterol content of bile, thereby decreasing cholesterol saturation and promoting the gradual dissolution of cholesterol-rich gallstones. It also exerts cytoprotective effects on hepatocytes by stabilizing cell membranes and reducing bile acid-induced apoptosis and inflammation. The drug improves liver enzyme levels and slows disease progression in cholestatic liver conditions. Hepatobest is generally well tolerated; common adverse effects may include mild gastrointestinal disturbances such as diarrhea, nausea, or abdominal discomfort. It is contraindicated in patients with complete biliary obstruction, acute cholecystitis, or hypersensitivity to the active ingredient. Dosage and duration of therapy should be individualized based on clinical response and liver function tests, under the supervision of a healthcare professional. Regular monitoring is recommended to assess therapeutic efficacy and detect potential adverse effects.